The Application of Generic Machine Learning to New Data Environments Requires “Something More” to be Patent Eligible READ MORE
Federal Circuit Affirms Presumption of Separateness in Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al., C.A. No. 24-2351 (Fed. Cir. Mar. 14, 2025) READ MORE
Defend & Deduct: How the Federal Circuit’s Actavis Decision Changes Tax Implications for ANDA Filers READ MORE
Andrew Wasson speaking at AIPLA CLE Web Series: Hot Topics in Chemical & Biotech Patent Practice READ MORE
Richard Kurz to speak at the New York City Bar Association – 2025 Intellectual Property Institute READ MORE
